Efficacy and safety of Qishen Yiqi dropping pills combined with modern medicine for coronary heart disease with ischemic heart failure: A systematic review and meta-analysis

医学 荟萃分析 出版偏见 漏斗图 科克伦图书馆 药丸 内科学 心力衰竭 优势比 冠状动脉疾病 置信区间 梅德林 心脏病学 药理学 政治学 法学
作者
Qiushan Man,Shi-Jian Chen,Xingyu Li
出处
期刊:Medicine [Wolters Kluwer]
卷期号:103 (44): e39927-e39927
标识
DOI:10.1097/md.0000000000039927
摘要

Background: Qishen Yiqi dropping pills combined with modern medicine have been widely used as a treatment for coronary heart disease with ischemic heart failure. Currently, there have been no robust studies addressing the efficacy and safety of Qishen Yiqi dropping pills combined with modern medicine for coronary heart disease with ischemic heart failure. Therefore, this systematic review and meta-analysis are conducted to fill in the gaps mentioned above. Methods: This systematic review was conducted and reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Relevant studies published from inception to April 17, 2023, in the 5 electronic databases: PubMed, The Cochrane Library, EMBASE, CNKI, and the Wanfang database were comprehensively searched. Weighted mean difference was used as the effect size for the continuous variables. Pooled odd ratios are presented if the results are binary variables. Additionally, we performed subgroup and sensitivity analyses to examine the source of heterogeneity. The funnel plot and the Egger test were used to estimate publication bias. Results: This meta-analysis included 46 studies involving 5843 participants. There is a significant difference in clinical efficacy, the 6-minute walk test (weighted mean difference = 50.10; 95% CI 28.19 to 72.02; I2 = 98.9%, P = .000), the indexes of ultrasonic cardiogram, blood biochemical indexes, and adverse effects (odds ratios = 0.46; 95% CI 0.29 to 0.75; I2 = 35.9%, P = .142). The sensitivity analysis and publication bias have demonstrated the robustness of the results ( P = .702). Conclusion: Qishen Yiqi dropping pills combined with modern medicine could significantly improve clinical efficacy without incasement adverse effects. Further studies are required to identify the more comprise efficacy and safety results.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S应助嘞是举仔采纳,获得10
刚刚
1秒前
谨慎的晓蕾完成签到 ,获得积分10
1秒前
2秒前
呃呃完成签到,获得积分10
2秒前
Rabbit发布了新的文献求助10
3秒前
4秒前
DDEEE发布了新的文献求助10
5秒前
慕青应助大喵采纳,获得10
5秒前
丘比特应助Xian采纳,获得10
6秒前
公冶笑白发布了新的文献求助10
7秒前
8秒前
Ploaris发布了新的文献求助10
8秒前
研友_Z63kg8发布了新的文献求助20
9秒前
呃呃发布了新的文献求助10
9秒前
调皮的千万完成签到,获得积分10
9秒前
Fengliguantou发布了新的文献求助10
10秒前
hecheng0511完成签到,获得积分10
10秒前
J.发布了新的文献求助20
12秒前
ShenLi应助QDU采纳,获得10
14秒前
领导范儿应助小垃圾采纳,获得10
19秒前
研友_Z63kg8完成签到,获得积分10
19秒前
22秒前
静一静完成签到,获得积分10
22秒前
23秒前
23秒前
ycccccc完成签到 ,获得积分10
23秒前
李健应助huangyikun采纳,获得10
24秒前
24秒前
小药同学完成签到,获得积分10
25秒前
宝贝丫头发布了新的文献求助10
26秒前
白桦林泪发布了新的文献求助10
27秒前
小药同学发布了新的文献求助10
27秒前
28秒前
嘞是举仔发布了新的文献求助10
28秒前
感性发布了新的文献求助10
29秒前
29秒前
30秒前
31秒前
孙燕应助芝士奶盖有点咸采纳,获得10
31秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989797
求助须知:如何正确求助?哪些是违规求助? 3531910
关于积分的说明 11255394
捐赠科研通 3270563
什么是DOI,文献DOI怎么找? 1805008
邀请新用户注册赠送积分活动 882157
科研通“疑难数据库(出版商)”最低求助积分说明 809190